Clinical Trial Update: Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease. [Phase 2]

View source ↗

Summary

Phase II study evaluating the efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution for Dry Eye Disease has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Lagricel Ofteno Ophthalmic Solution

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye | Phase 2 | Status: COMPLETED | Results posted: 2026-03-03